Arpan Mahanty, MS (Pharmaceutcs)

2014-2017 Department of Pharmaceutics China Pharmaceutical University 
 2017- Department of Health Technology and Informatics The Hong Kong Polytechnic University, Kowloon, Hong Kong 
Fluorescence molecular imaging, Multimodality imaging, Intraoperative/Intravital imaging, Drug delivery, Formulation, Molecular probe, Glioma, Immunology
"Arpan Mahanty"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Yang M, Mahanty A, Jin C, et al. (2022) Label-free metabolic imaging for sensitive and robust monitoring of anti-CD47 immunotherapy response in triple-negative breast cancer. Journal For Immunotherapy of Cancer. 10
Yang M, Oh IY, Mahanty A, et al. (2020) Immunotherapy for Glioblastoma: Current State, Challenges, and Future Perspectives. Cancers. 12
Banerjee P, Geng T, Mahanty A, et al. (2019) Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors. International Journal of Pharmaceutics
Chaurasiya B, Mahanty A, Roy D, et al. (2016) Influence of Tumor Microenvironment on the Distribution and Elimination of Nano-formulations. Current Drug Metabolism
Chaurasiya B, Mahanty A, Roy D, et al. (2016) Influence of tumor microenvironment on the distribution and elimination of nano-formulations Current Drug Metabolism. 17: 783-798
See more...